Ribociclib and Bicalutamide in AR+ TNBC

Clinical trial NCT03090165 · ACTIVE_NOT_RECRUITING

Trial details

NCT number: NCT03090165
Sponsor: Kari Wisinski
Status: ACTIVE_NOT_RECRUITING
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Triple Negative Breast Cancer

Start date: 2018-05-07
Primary completion: 2026-10-01
Enrollment: 37

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.